EnteroMedics makes stock moves to maintain Nasdaq listing
EnteroMedics Inc. has retired its Senior Amortizing Convertible Notes, converted all $18.75 million in notes to shares of common stock, as part of a strategy to regain compliance with the Nasdaq requirement that it have a minimum of $2.5 million of stockholders’ equity. Read More »